About Enhancer
| Enhancer ID: | E_01_0327 |
| Species: | human |
| Position : | chr16:86507633-86509633   |
| Biosample name: | |
| Experiment class : | High+Lowthroughput |
| Enhancer type: | Enhancer |
| Disease: | Pulmonary hypoplasia |
| Pubmed ID: | 30639323 |
| Enhancer experiment: | PCR, chip SEQ, variant enrichment analysis, bioinformatics prediction |
| Enhancer experiment description: | In contrast to ACDMPV caused by loss-of-function (LoF) of FOXF1 (MIM: 601089),20,21 the molecular etiology of AcDys and CAD is largely unknown. |
About Target gene
| Target gene : | -- |
| Strong evidence: | qRT-PCR,qPCR,ChIP,3C |
| Less strong evidence: | RNA-Seq |
| Target gene experiment description: | In contrast to ACDMPV caused by loss-of-function (LoF) of FOXF1 (MIM: 601089),20,21 the molecular etiology of AcDys and CAD is largely unknown. |
About TF
| TF name : | FOXF1 |
| TF experiment: | PCR?ChIP-seq??????????????? |
| TF experiment description: | In contrast to ACDMPV caused by loss-of-function (LoF) of FOXF1 (MIM: 601089),20,21 the molecular etiology of AcDys and CAD is largely unknown. |
About Function
| Enhancer function : | In contrast to ACDMPV caused by loss-of-function (LoF) of FOXF1 (MIM: 601089),20,21 the molecular etiology of AcDys and CAD is largely unknown. |
| Enhancer function experiment: | Immunohistochemical staining |
| Enhancer function experiment description: |
In contrast to ACDMPV caused by loss-of-function (LoF) of FOXF1 (MIM: 601089),20,21 the molecular etiology of AcDys and CAD is largely unknown. |
About SNP
| SNP ID: | -- |
Upstream Pathway Annotation of TF
| GeneName | Pathway Name | Source | Gene Number |
|---|---|---|---|
| FOXF1 | FOXA2 and FOXA3 transcription factor networks | pid | 45 |
Enhancer associated network
The number on yellow line represents the distance between enhancer and
target gene